CELLULAR RESPONSES TO INORGANIC PARTICULATES
细胞对无机颗粒的反应
基本信息
- 批准号:6171148
- 负责人:
- 金额:$ 47.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-07-22 至 2004-06-30
- 项目状态:已结题
- 来源:
- 关键词:biomaterial compatibility biomaterial interface interaction cellular immunity clinical research collagenase cytokine dental implants fluorescent dye /probe human subject implant interleukin 1 joint prosthesis lipopolysaccharides medical implant science particle silicates surface property tumor necrosis factor alpha
项目摘要
DESCRIPTION (adapted from the Investigator's abstract): Aseptic loosening of
prosthetic implant devices is the major long-term complication after total join
replacement (TIR). The local bone destruction (osteolysis) that characterizes
this condition can be attributed to the induction of a granulomatous
inflammatory reaction at the bone-implant interface. This tissue reaction is
initiated and perpetuated by the recruitment and activation of macrophages by
prosthetic wear debris. This application will focus on the physical-chemical
properties regulating cell responses to particulate orthopedic implant
materials, and will explore the potential role of endotoxin contamination in
mediating a component of the adverse cell responses. Specific Aim 1 will test
the hypothesis that particle surface chemistry and crystal structure are
critical determinants of the pattern and magnitude of cell responses.
Fluorescent-labeled particles of well characterized, size, shape, surface
chemistry and composition will be used to define the influence of specific
physical and chemical properties on protein adsorption, the kinetics of
particle internalization and cytokine release. These studies will exploit the
unique availability of submicron sized UHMWPE particles which exhibit
properties similar to authentic retrieved PE wear debris from failed implants.
Specific Aim 2 will test the hypothesis that: Lipopolysaccharide (LPS)
"contamination" accounts for a component of particle-induced cell responses.
These studies will define the differential capacity of particles with different
surface chemistry and crystallinity of bind LPS and will assess the effects of
particle-associated LPS on cell responses. Specific Aim 3 will test the
hypothesis that: the molecular pathways by which particles regulate the IL-1b
and TNF- genes differ and that particle-mediated effects involve LPS-dependent
and -independent signal transduction systems. These experimental approaches
will permit the dissection of the molecular mechanisms and signaling pathways
by which foreign particulate materials modulate cell responses. The overall
goal of these studies is to increase the understanding of the mechanisms by
which particulate wear debris generated from orthopedic (and dental) implants
regulate cell responses and to define rigorously the physical and chemical
properties that determine the biological activity of the particulate materials.
This information could lead to the development of targeted therapeutic
interventions for preventing or modulating the adverse cellular and tissue
reaction to wear particles. In addition, definition of the specific
physical-chemical properties responsible for cell activation could lead to the
introduction of materials that generate wear debris with reduced
pro-inflammatory properties.
描述(改编自研究者摘要):无菌松脱
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVEN GOLDRING其他文献
STEVEN GOLDRING的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVEN GOLDRING', 18)}}的其他基金
ProGel Technology for Better Management of Osteoarthritis Pain
ProGel 技术可更好地治疗骨关节炎疼痛
- 批准号:
10326409 - 财政年份:2020
- 资助金额:
$ 47.48万 - 项目类别:
ProGel Technology for Better Management of Osteoarthritis Pain
ProGel 技术可更好地治疗骨关节炎疼痛
- 批准号:
10013068 - 财政年份:2020
- 资助金额:
$ 47.48万 - 项目类别:
ProGel Technology for Better Management of Osteoarthritis Pain
ProGel 技术可更好地治疗骨关节炎疼痛
- 批准号:
10281291 - 财政年份:2020
- 资助金额:
$ 47.48万 - 项目类别:
GORDON CONFERENCE ON CELL AND MOLECULAR BIOLOGY OF BONES
骨骼细胞和分子生物学戈登会议
- 批准号:
2083284 - 财政年份:1995
- 资助金额:
$ 47.48万 - 项目类别:














{{item.name}}会员




